Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,786 | 19,284 | 30,522 | 42,993 | 51,189 |
| TOTAL | $17,488 | $21,269 | $32,763 | $45,806 | $56,496 |
| Non-Current Assets | |||||
| PPE Net | 30 | 41 | 61 | 64 | 82 |
| Other Non-Current Assets | 577 | 3,693 | 3,679 | 3,626 | 3,667 |
| TOTAL | $607 | $3,734 | $3,740 | $3,690 | $3,748 |
| Total Assets | $18,094 | $25,003 | $36,502 | $49,496 | $60,245 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 386 | 376 | 374 | 374 | 366 |
| Accounts payable and accrued liabilities | 2,349 | 3,006 | 4,191 | 3,168 | 2,666 |
| Accrued Expenses | 2,439 | 2,908 | 3,109 | 6,258 | 4,800 |
| TOTAL | $5,290 | $6,403 | $7,674 | $9,800 | $7,886 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,524 | 2,033 | 2,046 | 2,135 | 2,094 |
| TOTAL | $5,524 | $2,442 | $2,455 | $2,544 | $2,503 |
| Total Liabilities | $10,814 | $8,844 | $10,129 | $12,344 | $10,389 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 109 | 87 | 77 | 76 | 76 |
| Retained earnings | -224,627 | -213,568 | -203,041 | -188,961 | -175,701 |
| Other shareholders' equity | 777 | 762 | 768 | 785 | 766 |
| TOTAL | $7,281 | $16,159 | $26,373 | $37,153 | $49,856 |
| Total Liabilities And Equity | $18,094 | $25,003 | $36,502 | $49,496 | $60,244 |